Association between Clinical Frailty Scale and mortality 24 months after hospitalisation in adult patients with COVID-19.

ABSTRACT:

Background

The clinical frailty scale (CFS) was used as a triage tool for medical decision making during the COVID-19 pandemic. The CFS has been posed as a suitable risk marker for in-hospital mortality in COVID-19 patients. We evaluated whether the CFS is associated with mortality 24 months after hospitalisation for COVID-19.

Methods

The COvid MEdicaTion (COMET) study is an international, multicentre, observational cohort study, including adult patients hospitalised for COVID-19 between March 2020-July 2020. Patients' characteristics, prescribed medication, clinical characteristics, and CFS were collected at admission, survival data were collected 24 months after hospitalisation. Multivariable cox proportional hazard models stratified by age (<65 and ≥65 years), and adjuste

SUBMITTER: Minnema J 

PROVIDER: S-EPMC11648057 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature